Newly Approved Mepolizumab Mitigates COPD Exacerbations
Heidi Splete May 27, 2025 Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the MATINEE study presented at the American Thoracic Society (ATS) 2025 International Conference. Based on these findings, mepolizumab is newly approved by the US Food and […]
Newly Approved Mepolizumab Mitigates COPD Exacerbations Read More »
